Back
Neumora Therapeutics, Inc. 10K Form
Sell
37
NMRA
Neumora Therapeutics, Inc.
Last Price:
$1.96
Seasonality Move:
-24.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NMRA News And Ratings
See the #1 stock for the next 7 days that we like better than NMRA
NMRA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-46.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.82 |
| Price / Book: | 2.64 |
Profitability
| EPS (TTM): | -1.46330 |
|---|---|
| Net Income (TTM): | $-236.3M |
| Gross Margin: | $-631K |
| Return on Equity: | -102.63% |
| Return on Assets: | -88.97% |
Neumora Therapeutics, Inc. Earnings Forecast
Key Neumora Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 1 years.
Neumora Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NMRA |
| Website: | neumoratx.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 6.85 |
| Quick Ratio: | 6.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NMRA Technical Analysis vs Fundamental Analysis
Sell
37
Neumora Therapeutics, Inc. (NMRA)
is a Sell
Is Neumora Therapeutics, Inc. a Buy or a Sell?
-
Neumora Therapeutics, Inc. stock is rated a SellThe current Neumora Therapeutics, Inc. [NMRA] share price is $2.09. The Score for NMRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.